NCT01929525

Brief Summary

Effectiveness of silver nitrate solution in treatment of anal fistula is is aimed to be investigated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

August 19, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 28, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

August 28, 2013

Status Verified

August 1, 2013

Enrollment Period

5 months

First QC Date

August 19, 2013

Last Update Submit

August 22, 2013

Conditions

Anal Fistula

Outcome Measures

Primary Outcomes (1)

  • Number of anal fistula patients treated with silver nitrate solution.

    The primary end point in the study was to assess the efficacy of the silver nitrate in the treatment of anal fistula. The number of anal fistula patients who are treated with silver nitrate solution will be calculated. The role of silver nitrate solution in anal fistula treatment will be investigated

    1 year

Secondary Outcomes (1)

  • Therapeutic factors

    1 year

Study Arms (1)

Silver Nitrate

Irrigation of fistula tract with 1% silver nitrate solution for all patients who accepts the study and signed the written informed consent form.

Eligibility Criteria

Age18 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with the diagnosis of anal fistula

You may qualify if:

  • All patients with the diagnosis of anal fistula Patients with recurrence

You may not qualify if:

  • Patients who do not sign the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MarmaraUSM

Istanbul, Istanbul, 34893, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Rectal Fistula

Condition Hierarchy (Ancestors)

Intestinal FistulaDigestive System FistulaDigestive System DiseasesIntestinal DiseasesGastrointestinal DiseasesRectal DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • S.CUMHUR YEGEN, MD

    Marmara University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant profesor of surgery

Study Record Dates

First Submitted

August 19, 2013

First Posted

August 28, 2013

Study Start

August 1, 2013

Primary Completion

January 1, 2014

Study Completion

March 1, 2014

Last Updated

August 28, 2013

Record last verified: 2013-08

Locations

TU(1)